Nutropin Depot was FDA approved for the long-term treatment of growth failure due to lack of adequate endogenous growth hormone secretion in pediatric patients on December 22, 1999. There are currently ongoing Phase II/III clinical trials to evaluate Nutropin Depot's safety and efficacy in the treatment of adult GHD.
I am anxiously awaiting the results of these trials.
I am anxiously awaiting the results of these trials.